Genmab A/S (GNMSF) Short Interest Ratio & Short Volume $198.51 -6.49 (-3.17%) As of 07/3/2025 12:46 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Genmab A/S Short Interest DataGenmab A/S (GNMSF) has a short interest of 44,700 shares, representing 0.07% of the float (the number of shares available for trading by the public). This marks a -62.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 111.8, indicating that it would take 111.8 days of the average trading volume of 37 shares to cover all short positions.Current Short Interest44,700 sharesPrevious Short Interest117,900 sharesChange Vs. Previous Month-62.09%Dollar Volume Sold Short$10.03 millionShort Interest Ratio111.8 Days to CoverLast Record DateJune 15, 2025Outstanding Shares66,070,000 sharesShort Percent of Float0.07%Today's Trading Volume24 sharesAverage Trading Volume37 sharesToday's Volume Vs. Average65% Short Selling Genmab A/S? Sign up to receive the latest short interest report for Genmab A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNMSF Short Interest Over TimeGNMSF Days to Cover Over TimeGNMSF Percentage of Float Shorted Over Time Genmab A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202544,700 shares $10.03 million -62.1%0.1%111.8 $224.30 5/31/2025117,900 shares $24.49 million -19.4%0.2%1179 $207.75 5/15/2025146,300 shares $27.62 million +98.0%0.2%43 $188.80 4/30/202573,900 shares $15.15 million +1.2%N/A246.3 $204.98 4/15/202573,000 shares $13.91 million +30.1%0.1%4.3 $190.50 3/31/202556,100 shares $10.65 million +3.9%0.1%561 $189.80 3/15/202554,000 shares $11.28 million -11.6%0.1%180 $208.89 2/28/202561,100 shares $13.75 million -23.5%0.1%203.7 $224.97 2/15/202579,900 shares $16.86 million -1.2%0.1%21.6 $210.97 1/31/202580,900 shares $15.97 million -20.5%N/A3.8 $197.44 Get the Latest News and Ratings for GNMSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025101,800 shares $20.57 million -16.6%N/A28.3 $202.06 12/31/2024122,000 shares $25.30 million +2.3%N/A16.9 $207.38 12/15/2024119,300 shares $23.98 million +9.5%N/A26.5 $201.00 11/30/2024109,000 shares $23.16 million +2.8%N/A7.2 $212.50 11/15/2024106,000 shares $22.55 million +38.9%N/A6.6 $212.71 10/31/202476,300 shares $16.67 million -10.1%N/A4.7 $218.47 10/15/202484,900 shares $19.93 million -19.1%N/A6.7 $234.80 9/30/2024104,900 shares $24.61 million -50.8%N/A80.7 $234.65 9/15/2024213,000 shares $55.32 million +3.3%N/A142 $259.72 8/31/2024206,200 shares $56.67 million +11.1%N/A114.6 $274.83 8/15/2024185,600 shares $49.24 million -1.2%N/A44.2 $265.28 7/31/2024187,900 shares $52.13 million +4.0%N/A19.4 $277.44 7/15/2024180,700 shares $46.58 million +19.5%N/A106.3 $257.77 6/30/2024151,200 shares $37.12 million +28.2%N/A116.3 $245.49 6/15/2024117,900 shares $30.47 million -0.6%N/A107.2 $258.44 5/31/2024118,600 shares $32.69 million +9.0%N/A107.8 $275.67 5/15/2024108,800 shares $31.72 million -49.4%N/A181.3 $291.54 4/30/2024214,900 shares $58.93 million +26.6%N/A126.4 $274.22 4/15/2024169,700 shares $47.86 million +7.3%N/A169.7 $282.00 3/31/2024158,100 shares $48.47 million -3.5%N/A175.7 $306.59 3/15/2024163,800 shares $49.40 million -4.1%N/A136.5 $301.60 2/29/2024170,800 shares $47.55 million +24.1%N/A27.5 $278.41 2/15/2024137,600 shares $39.55 million -11.6%N/A86 $287.40 1/15/202430,700 shares $9.65 million -4.7%N/A16.2 $314.40 12/31/202332,200 shares $10.17 million -1.5%N/A16 $315.70 12/15/202332,700 shares $10.19 million +1.6%N/A12.1 $311.50 11/30/202332,200 shares $10.27 million -42.7%N/A16.9 $319.00 11/15/202356,200 shares $18.21 million +102.2%N/A25.5 $324.07 10/31/202327,800 shares $7.98 million +1.1%N/A23.2 $287.10 10/15/202327,500 shares $8.77 million +10.0%N/A45.8 $319.00Crypto Is Pumping Again – Now Comes the Real Opportunity (Ad)This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.Crypto’s Most Powerful Signal Just Triggered - PLUS Claim your $10 in Bitcoin 9/30/202325,000 shares $8.91 million +113.7%N/A41.7 $356.30 9/15/202311,700 shares $4.40 million -0.9%N/A7.8 $376.20 8/31/202311,800 shares $4.47 million +6.3%N/A15.6 $379.20 8/15/202311,100 shares $4.09 million -31.5%N/A27.8 $368.40 7/31/202316,200 shares $6.65 million -38.2%N/A23.1 $410.40 7/15/202326,200 shares $10.36 million -36.7%N/A18.7 $395.43 6/30/202341,400 shares $15.51 million +19.7%N/A37.6 $374.57 6/15/202334,600 shares $13.30 million -5.5%N/A38.4 $384.50 5/31/202336,600 shares $14.46 million -42.6%N/A73.2 $394.99 5/15/202363,800 shares $27.06 million +69.2%N/A91.1 $424.10 4/30/202337,700 shares $15.41 million -37.5%N/A75.4 $408.70 4/15/202360,300 shares $24.87 million -28.4%N/A67 $412.50 3/31/202384,200 shares $31.47 million -18.7%N/A210.5 $373.75 3/15/2023103,600 shares $36.80 million +143.2%N/A172.7 $355.25 2/28/202342,600 shares $15.90 million -56.0%N/A60.9 $373.25 2/15/202396,900 shares $38.21 million +8.8%N/A193.8 $394.30 1/31/202389,100 shares $34.93 million -3.3%N/A148.5 $392.00 1/15/202392,100 shares $37.12 million +37.3%N/A153.5 $403.00 12/30/202267,100 shares $28.69 million +527.1%N/A41.9 $427.50 12/15/202210,700 shares $4.77 million +78.3%N/A3.8 $445.52 11/30/20226,000 shares $2.75 million -25.0%N/A10 $457.50 11/15/20228,000 shares $3.38 million +14.3%N/A6.7 $422.43 10/31/20227,000 shares $2.69 million -51.7%N/A0.8 $384.30 10/15/202214,500 shares $5.35 million +20.8%N/A11.2 $368.80 9/30/202212,000 shares $3.84 million +10.1%N/A10.9 $320.21 9/15/202210,900 shares $3.88 million -71.7%N/A7.8 $356.25 8/31/202238,500 shares $13.59 million -31.0%N/A55 $353.01 8/15/202255,800 shares $20.85 million +30.1%N/A27.9 $373.61 7/31/202242,900 shares $14.95 million +257.5%N/A39 $348.50 7/15/202212,000 shares $4.09 million -87.2%N/A7.1 $341.16 6/30/202294,000 shares $30.58 million -30.0%N/A16.2 $325.29 6/15/2022134,200 shares $36.61 million +63.7%N/A63.9 $272.80 5/31/202282,000 shares $24.77 million -60.0%N/A8 $302.08 5/15/2022204,900 shares $59.57 million +7.1%N/A113.8 $290.75 4/30/2022191,300 shares $69.71 million +92.7%N/A273.3 $364.42 4/15/202299,300 shares $36.64 million +95.9%N/A66.2 $368.95 3/31/202250,700 shares $18.10 million -4.7%N/A56.3 $357.10 3/15/202253,200 shares $18.22 million -23.8%N/A44.3 $342.42 2/28/202269,800 shares $23.25 million +13.1%N/A34.9 $333.03 2/15/202261,700 shares $20.30 million +5.5%N/A26.8 $328.98 1/31/202258,500 shares $20.03 million +290.0%N/A26.6 $342.38 1/15/202215,000 shares $5.16 million -38.3%N/A10 $344.28 12/31/202124,300 shares $9.49 million -66.7%N/A24.3 $390.53 12/15/202172,900 shares $27.46 million +74.0%N/A11.4 $376.72 11/30/202141,900 shares $15.97 million -17.8%N/A41.9 $381.08 11/15/202151,000 shares $21.14 million +351.3%N/A85 $414.58 10/29/202111,300 shares $5.09 million -33.5%N/A7.1 $450.50 10/15/202117,000 shares $7.60 million +33.9%N/A24.3 $446.95 9/30/202112,700 shares $5.37 million -11.8%N/A25.4 $423.08 9/15/202114,400 shares $6.08 million +25.2%N/A13.1 $422.08Crypto Is Pumping Again – Now Comes the Real Opportunity (Ad)This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.Crypto’s Most Powerful Signal Just Triggered - PLUS Claim your $10 in Bitcoin 8/31/202111,500 shares $5.49 million +0.9%N/A28.8 $477.57 8/13/202111,400 shares $5.18 million +22.6%N/A16.3 $454.38 7/30/20219,300 shares $4.17 million +34.8%N/A5.2 $448.87 7/15/20216,900 shares $3.03 million -13.8%N/A11.5 $438.47 6/30/20218,000 shares $3.38 million -31.6%N/A6.7 $422.32 6/15/202111,700 shares $5.10 million -58.4%N/A14.6 $435.68 5/28/202128,100 shares $11.52 million -64.5%N/A56.2 $409.92 5/14/202179,100 shares $29.48 million -26.7%N/A197.8 $372.72 4/30/2021107,900 shares $40.45 million +6.6%N/A269.8 $374.92 4/15/2021101,200 shares $35.77 million +19.8%N/A44 $353.50 3/31/202184,500 shares $26.73 million +14.8%N/A24.9 $316.28 3/15/202173,600 shares $23.74 million +46.0%N/A73.6 $322.50 2/26/202150,400 shares $17.39 million -40.1%N/A16.8 $345.00 2/12/202184,100 shares $34.26 million +557.0%N/A120.1 $407.32 1/29/202112,800 shares $5.26 million +12.3%N/A8 $411.00 1/15/202122,900 shares $10.04 million +97.4%N/A45.8 $438.42 12/31/202029,700 shares $12.01 million +29.7%N/A74.3 $404.45 12/15/202022,900 shares $8.95 million +97.4%N/A45.8 $390.69 11/30/202011,600 shares $4.35 million -11.5%N/A9.7 $375.01 11/15/202013,100 shares $4.81 million +13.9%N/A14.6 $366.96 10/30/202011,500 shares $3.98 million No ChangeN/A12.8 $346.21 10/15/202011,500 shares $4.43 million -35.0%N/A38.3 $385.31 9/30/202017,700 shares $6.50 million -80.7%N/A14.8 $367.16 9/15/202091,800 shares $34.27 million +37.2%N/A76.5 $373.30 8/31/202066,900 shares $25.24 million +5.5%N/A47.8 $377.29 8/14/202063,400 shares $23.14 million -11.3%N/A52.8 $365.04 7/31/202071,500 shares $23.95 million -0.4%N/A102.1 $334.90 7/15/202071,800 shares $25.35 million -30.5%N/A102.6 $353.00 GNMSF Short Interest - Frequently Asked Questions What is Genmab A/S's current short interest? Short interest is the volume of Genmab A/S shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 44,700 shares of GNMSF short. 0.07% of Genmab A/S's shares are currently sold short. Learn More on Genmab A/S's current short interest. What is a good short interest ratio for Genmab A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNMSF shares currently have a short interest ratio of 112.0. Learn More on Genmab A/S's short interest ratio. What is a good short interest percentage for Genmab A/S? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of Genmab A/S's floating shares are currently sold short. Is Genmab A/S's short interest increasing or decreasing? Genmab A/S saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 44,700 shares, a decrease of 62.1% from the previous total of 117,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genmab A/S's short interest compare to its competitors? 0.07% of Genmab A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genmab A/S: Takeda Pharmaceutical Co. (0.21%), Daiichi Sankyo Co., Ltd. - Sponsored ADR (0.00%), argenex SE (3.39%), BioNTech SE Sponsored ADR (2.58%), Teva Pharmaceutical Industries Ltd. (3.50%), Insmed, Inc. (6.33%), Summit Therapeutics PLC (27.22%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S Sponsored ADR (0.36%), Dr. Reddy's Laboratories Ltd (1.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Genmab A/S stock? Short selling GNMSF is an investing strategy that aims to generate trading profit from Genmab A/S as its price is falling. GNMSF shares are trading down $6.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genmab A/S? A short squeeze for Genmab A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNMSF, which in turn drives the price of the stock up even further. How often is Genmab A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNMSF, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies TAK Short Interest DSNKY Short Interest ARGX Short Interest BNTX Short Interest TEVA Short Interest INSM Short Interest SMMT Short Interest ITCI Short Interest GMAB Short Interest RDY Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GNMSF) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
